| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.48 | 6e-49 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-19 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-14 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.34 | 5e-11 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 8e-09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |